[Role of oxaliplatin in the treatment of colorectal neoplasms].
Sobrero
A
A
Cattedra di Oncologia Medica, Università di Udine. sobrero@uniud.it
Grossi
F
F
Guglielmi
A
A
D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000494:pharmacology; D003110:Colonic Neoplasms / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D000077146:Irinotecan; D009944:Organoplatinum Compounds / Q000737:chemistry / Q000627:therapeutic use*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin